查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1870706

生物活性玻璃市场：按应用、产品类型、形态、最终用户和分销管道划分 - 全球预测（2025-2032年）

Bioactive Glass Market by Application, Product Type, Form, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物活性玻璃市场将成长至 509 亿美元，复合年增长率为 8.44%。

关键市场统计数据
基准年 2024 266.1亿美元
预计年份：2025年 288.9亿美元
预测年份 2032 509亿美元
复合年增长率 (%) 8.44%

本文全面介绍了生物活性玻璃技术，概述了其临床相关性、材料演变以及在医疗应用中的转化意义。

生物活性玻璃从一项突破性的实验室发现发展成为多种临床和研究应用的基础材料。最初，人们开发生物活性玻璃是因为它具有与骨骼和软组织结合的独特能力。如今，现代的成分和加工技术已将其应用范围扩展到牙科修復材料、药物递送基质、整形外科植入和人工组织支架等领域。溶胶-凝胶化学、离子取代和表面功能化技术的进步，使得生物活性玻璃不仅能够支持结构修復，还能主动调节细胞反应和局部微环境。

材料创新、临床需求和监管演变如何融合，重塑生物活性玻璃领域的产品开发和商业化路径

近年来，科学、临床和商业性因素的共同作用，促使生物活性玻璃领域发生了变革性转变。在科学方面，玻璃化学和积层製造技术的进步，使得可控孔隙率和离子释放特性的客製化结构成为可能，从而促进可重复的生物反应。同时，表面涂层和复合材料整合技术的进步，提高了植入的耐久性和生物相容性，减少了发炎反应，并增强了骨整合。

评估2025年关税政策趋势如何重塑生物活性玻璃价值链的供应链策略、製造地和定价槓桿。

近期政策週期中关税的征收和加强，为生物活性玻璃价值链上的各公司带来了复杂的营运和策略影响。关税改变了进口原料前驱物（例如硅和钙源）、溶胶-凝胶加工中使用的特种试剂以及跨境采购的成品组件的成本基础。对于依赖一体化全球供应链的製造商而言，这些成本波动需要重新评估其筹资策略、库存管理政策和跨境转移定价。

将临床应用、配方选择、产品形式、终端用户偏好和通路与商业性成果联繫起来的综合細項分析

细分市场分析揭示了临床需求、产品创新和分销动态的交汇点，突显了技术发展和商业性重点领域。从应用角度来看，牙科涵盖牙髓病学和牙周病学，致力于满足牙齿结构及其周围组织的再生需求。药物传递利用生物活性玻璃作为抗菌剂和生长因子的缓释性基质。整形外科专注于骨再生和脊椎融合手术，其中支架和离子释放至关重要。组织工程涵盖骨骼、软骨和血管组织，每种组织都需要不同的机械性质和生物功能特性。

区域趋势和不同的采用模式将影响监管策略和市场发展。

在生物活性玻璃应用领域，区域趋势对技术采纳、监管成熟度和供应链策略的形成至关重要。在美洲，牙科创新和整形外科植入研发活动活跃，临床系统和报销环境通常支持实证应用。製造能力和一体化的牙科供应链支援快速商业化和临床医生培训计画。欧洲、中东和非洲地区的情况则较为复杂，一些欧洲市场的监管协调统一，而其他地区的准入和采购机制则各不相同。这导致该地区既有集中核准，也有以成本效益和临床结果为重点的本地化应用策略。

企业策略和协作方式定义了生物活性玻璃製造商之间的竞争差异化、扩充性和临床检验路径。

在生物活性玻璃生态系统中，企业层面的行为反映了不同的策略姿态，这取决于其规模、技术背景和市场重点。跨国材料製造商正投资于模组化生产线和跨境监管团队，以适应各种不同的成分和几何形状，而规模较小的专业公司则专注于小众临床适应症、高价值牙科耗材或独特的支架结构。Start-Ups和学术机构往往是颠覆性创新的驱动力，尤其是在积层製造和生物功能化技术领域，但它们通常选择与现有经销商或联合开发伙伴合作，以进入临床管道并扩大生产规模。

针对产品、监管、供应链和商业策略，提出切实可行的、优先排序的建议，以加速临床应用并增强组织韧性。

为了加速技术应用，产业领导者应将研发重点与清晰的临床价值提案和实证实践相结合。投资于平台技术，实现跨产品线的配方可调，从而使单一生产平台能够生产用于不同适应症的涂层、粉末、腻子和支架。在材料开发的同时，制定一套系统的转化证据生成计划，包括严格的临床前终点、尽可能开展多中心临床试验以及收集真实世界数据，以证明功能性结果和手术效率。

采用混合方法研究框架，结合专家访谈、文献综合和情境分析，以可靠地检验技术、临床和商业性的发现。

本调查方法融合了定性专业知识和系统性的证据综合，以确保得出可靠且实用的结论。主要研究包括对牙科和整形外科医生、医院和诊所采购经理、材料和器械製造商的技术经理以及监管专家进行结构化访谈。这些访谈深入了解了对实施决策至关重要的操作偏好、操作特性和临床终点。次要研究包括对同行评审文献、监管指导文件、临床试验註册库和已发布的技术标准进行主题回顾，以验证性能声明和安全性考虑因素。

总之，我们的综合分析表明，产品、证据和供应策略的协调一致将决定生物活性玻璃技术的采用路径和临床影响。

摘要，生物活性玻璃正处于一个十字路口，成熟的材料科学、细緻入微的临床需求和不断发展的商业结构正在汇聚，为更广泛的应用铺平道路。该技术的核心优势——生物活性、可调控的溶解特性和功能性离子释放能力——与牙科修復、整形外科再生和组织工程等领域的临床目标高度契合。然而，要充分发挥这些材料的潜力，需要在产品设计、临床证据产生和供应链策略等方面进行协调努力。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将3D列印支架与生物活性玻璃复合材料结合用于骨组织再生
  • 开发用于标靶药物传递的多功能生物活性玻璃奈米纤维
  • 拓展用于整形外科植入的生物活性玻璃涂层，以增强其抗菌性能
  • 介绍一种利用农业废弃物生产生物活性玻璃的永续方法
  • 增加对生物活性玻璃在牙科组织再生疗法临床试验的投资
  • 开发含有抗菌银奈米粒子的生物活性玻璃基伤口敷料
  • 透过生物技术公司与学术机构的合作，加速生物活性玻璃创新进程
  • 组织工程中越来越多地使用掺杂生物活性玻璃配方来促进血管生成

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 生物活性玻璃市场及其应用

  • 牙科
    • 用于根管治疗
    • 牙周病治疗
  • 药物输送
  • 整形外科
    • 骨再生
    • 脊椎融合手术
  • 组织工程
    • 骨组织
    • 软骨组织
    • 血管组织

第九章 生物活性玻璃市场（依产品类型划分）

  • 13-93
  • 45S5
  • 58S
  • S53P4

第十章 生物活性玻璃市场（按类型划分）

  • 涂层
  • 粉末
  • 油灰
  • 鹰架

第十一章 依最终用户分類的生物活性玻璃市场

  • 牙医诊所
  • 医院
  • 研究所

第十二章 生物活性玻璃市场（依通路划分）

  • 直销
  • 经销商

第十三章 生物活性玻璃市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 生物活性玻璃市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国生物活性玻璃市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Stryker Corporation
    • 3M Company
    • NovaBone Products, LLC
    • Mo-Sci Corporation
    • Bonalive Biomaterials Ltd
    • Biomin GmbH
    • Orthovita, Inc.
    • Shanghai Bio-lu Biomaterials Co., Ltd.
    • CoorsTek, Inc.
    • AGC Inc.
Product Code: MRR-1A1A064C02E5

The Bioactive Glass Market is projected to grow by USD 50.90 billion at a CAGR of 8.44% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.61 billion
Estimated Year [2025] USD 28.89 billion
Forecast Year [2032] USD 50.90 billion
CAGR (%) 8.44%

A comprehensive contextual introduction to bioactive glass technology outlining its clinical relevance, material evolution, and translational significance across healthcare applications

Bioactive glass has transitioned from a laboratory breakthrough to a cornerstone material across multiple clinical and research domains. Initially developed for its unique ability to bond with bone and soft tissues, modern compositions and processing techniques have expanded its utility into dental restoratives, drug delivery matrices, orthopedic implants, and engineered tissue scaffolds. Advances in sol-gel chemistry, ion substitution, and surface functionalization now enable materials that not only support structural repair but actively modulate cellular responses and local microenvironments.

This introduction frames the technology's relevance to clinicians, materials scientists, and commercial strategists. In clinical practice, bioactive glass applications span endodontic procedures and periodontal therapies in dentistry, while orthopedics leverages formulations for bone regeneration and fusion. In parallel, tissue engineering research exploits compositional tuning to promote osteogenesis, chondrogenesis, and vascularization. Coupled with varied product forms such as coatings, powders, putties, and scaffolds, these developments underpin a diversified supply chain from specialized manufacturers to hospital procurement.

As regulatory pathways evolve and translational pipelines accelerate, understanding the material science alongside clinical evidence and distribution dynamics becomes essential. This report synthesizes the technical foundations and application contexts to equip leaders with a clear orientation of where bioactive glass delivers differentiated clinical value and where further innovation is required to overcome adoption barriers.

How material innovation, clinical demand, and regulatory evolution are collectively reshaping product development and commercialization pathways in the bioactive glass sector

Recent years have witnessed transformative shifts across the bioactive glass landscape driven by converging scientific, clinical, and commercial forces. At the scientific front, precision in glass chemistry and additive manufacturing have enabled bespoke architectures with controlled porosity and ion release profiles, which in turn drive more reproducible biological responses. Parallel improvements in surface coatings and composite integration have expanded implant longevity and compatibility, reducing inflammatory responses and enhancing osseointegration.

Clinically, there is a discernible move from single-use, filler-type applications toward multifunctional constructs that combine structural repair with localized therapeutic delivery. This paradigm shift reflects broader healthcare priorities emphasizing minimally invasive procedures, faster recovery times, and lower infection risks. Commercially, strategic alliances between materials firms, dental suppliers, and implant manufacturers are reshaping route-to-market strategies, concentrating on bundled solutions that simplify clinician workflows and procurement.

Regulatory expectations and payer scrutiny are also evolving; device dossiers increasingly require robust preclinical models, histological endpoints, and translational biomarkers to substantiate clinical benefits. Consequently, organizations that align their R&D, regulatory, and clinical evidence-generation strategies are better positioned to navigate reimbursement landscapes and accelerate adoption. Taken together, these shifts indicate a maturing field where incremental material advances are being translated into systemic changes in how therapies are designed, delivered, and valued.

Assessing how tariff policy dynamics in 2025 have reoriented supply chain strategies, manufacturing footprints, and pricing levers across the bioactive glass value chain

The imposition and escalation of tariffs in recent policy cycles have introduced a complex set of operational and strategic impacts for companies engaged in the bioactive glass value chain. Tariffs alter the cost basis for imported raw precursors such as silicon and calcium sources, specialized reagents used in sol-gel processing, and finished components supplied across borders. For manufacturers relying on integrated global supply chains, these cost shifts necessitate reassessment of sourcing strategies, inventory policies, and cross-border transfer pricing.

Beyond direct cost effects, tariffs influence competitive positioning. Organizations with localized manufacturing footprints or vertical integration can internalize fewer external cost shocks, creating relative advantages in margin stability and price competitiveness. Conversely, firms dependent on third-party suppliers or contract manufacturers in tariff-affected jurisdictions face margin compression or must accept lead-time variability as procurement shifts to alternative suppliers.

Operationally, some companies respond by redesigning bills of materials to reduce tariff exposure, substituting components where clinically and regulatory feasible, or increasing emphasis on domestic supply relationships. Others accelerate investments in automation and process efficiency to offset rising input costs without compromising clinical specifications. Importantly, tariffs also amplify the strategic value of distribution choices: direct sales channels enable tighter margin control and dynamic pricing, whereas reliance on distributors can diffuse tariff-related costs across broader networks but may conceal incremental pricing pressures from end-users. Overall, the tariff environment in 2025 has elevated supply chain resilience and manufacturing localization from tactical priorities to central pillars of corporate strategy.

Integrated segmentation analysis connecting clinical applications, compositional choices, product forms, end-user preferences, and distribution pathways to commercial outcomes

Segmentation insights reveal where clinical demand intersects with product innovation and distribution dynamics, highlighting areas of concentrated technical development and commercial focus. When viewed through the lens of application, dentistry encompasses both endodontic applications and periodontal treatment, addressing regenerative needs inside and around the tooth structure; drug delivery leverages bioactive glass as a controlled-release matrix for antimicrobials and growth factors; orthopedics is oriented toward bone regeneration and spinal fusion procedures where scaffold architecture and ion release are paramount; and tissue engineering spans bone tissue, cartilage tissue, and vascular tissue, each demanding distinct mechanical and biofunctional profiles.

Examining product type sheds light on compositional preferences and performance trade-offs. Classic formulations such as 13-93 and 45S5 remain reference points for bioactivity and dissolution behavior, while variants like 58S and S53P4 are selected for specific angiogenic or antimicrobial attributes. Form factor decisions-coating, powder, putty, and scaffold-reflect clinical workflows and handling requirements; coatings are optimized for implant surfaces, powders and putties for defect filling and minimally invasive delivery, and scaffolds when structural support and cell infiltration are required. End users include dental clinics, hospitals, and research institutes, each placing different emphases on ease of use, regulatory branding, and evidence thresholds. Finally, distribution choices between direct sales and distributors influence market reach, pricing transparency, and the ability to offer integrated training or product bundling. Together, these segmentation dimensions map the technical design choices to real-world clinical adoption patterns and commercial pathways.

Regional dynamics and differential adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping regulatory strategy and market deployment

Regional dynamics are pivotal in shaping technology adoption, regulatory maturity, and supply chain strategies across bioactive glass applications. In the Americas, clinical systems and reimbursement environments frequently favor evidence-driven adoption, with strong activity in dental innovation and orthopedic implant development; manufacturing capacity and consolidated dental supply channels support rapid commercialization and clinician training programs. Europe, the Middle East & Africa presents a heterogenous landscape where regulatory harmonization in some European markets contrasts with varied access and procurement mechanisms in other jurisdictions, driving a mix of centralized approvals and localized adoption strategies that emphasize cost-effectiveness and clinical outcomes.

Asia-Pacific markets are characterized by both fast-growing clinical demand and significant manufacturing capabilities. Several countries in the region are notable for rapid hospital infrastructure expansion and active research ecosystems that advance translational applications in tissue engineering and drug delivery. These regional differences influence decisions on where to locate pilot production, how to design clinical evidence packages, and the nature of partnerships with local distributors or clinical networks. Navigating the nuanced regulatory, reimbursement, and procurement realities across these regions is essential for firms seeking scalable international rollouts and for tailoring product portfolios to local clinical and cost constraints.

Corporate strategies and collaborative approaches that determine competitive differentiation, scalability, and clinical validation trajectories across bioactive glass producers

Company-level behaviors within the bioactive glass ecosystem demonstrate divergent strategic postures depending on scale, technical heritage, and market focus. Multinational materials manufacturers are investing in modular production lines and cross-border regulatory teams to support a range of compositions and form factors, while smaller specialized firms concentrate on niche clinical indications, high-value dental consumables, or proprietary scaffold architectures. Startups and university spinouts often drive disruptive technical innovations, particularly in additive manufacturing and biofunctionalization, but they frequently partner with established distributors or co-development partners to access clinical channels and scale manufacturing.

Across these organizational types, successful companies share several common practices: disciplined IP strategies that protect formulation specificity and processing know-how; early engagement with regulatory bodies to streamline approval pathways; and investment in post-market evidence collection to demonstrate long-term clinical benefits. Firms are also differentiating via service layers such as clinician training, procedural support, and bundled implant systems that reduce the complexity of adoption. Strategic M&A and licensing arrangements are occurring where larger players seek to internalize specialized capabilities, while collaborative consortia with hospitals and research institutes accelerate clinical validation. Overall, corporate insights point toward a balanced mix of technological depth, regulatory acumen, and commercialization partnerships as determinants of competitive advantage.

Practical and prioritized recommendations for product, regulatory, supply chain, and commercial strategies that accelerate clinical adoption and organizational resilience

Industry leaders should align R&D priorities with clear clinical value propositions and evidence pathways to accelerate adoption. Invest in platform technologies that allow compositional tuning across a family of products so that a single manufacturing backbone can deliver coatings, powders, putties, and scaffolds adapted to different indications. Parallel to material development, create a structured plan for generating translational evidence that includes rigorous preclinical endpoints, multicenter clinical studies where feasible, and real-world data collection to demonstrate functional outcomes and procedural efficiencies.

Operationally, diversify supply chain sources and examine regional manufacturing or toll-production options to reduce exposure to tariff volatility and logistics disruptions. Adopt modular production practices and quality systems that facilitate rapid validation of new compositions without extensive requalification. Commercially, tailor go-to-market models by region and end user: dental clinics often favor products that reduce chair time and simplify protocols, hospitals emphasize integrated implant systems with predictable inventory management, and research institutes seek open platforms that enable collaborative studies. Finally, cultivate strategic partnerships spanning distribution, clinical research, and complementary implant technologies to extend reach and share risk in evidence generation. Executing on these recommendations will improve resilience, accelerate clinical uptake, and create defensible differentiation in a competitive field.

A mixed-methods research framework combining expert interviews, literature synthesis, and scenario analysis to validate technical, clinical, and commercial insights reliably

The research methodology integrates qualitative expertise with systematic evidence synthesis to ensure robust, actionable conclusions. Primary research comprised structured interviews with clinicians across dentistry and orthopedics, procurement leaders from hospitals and clinics, technical leaders at materials and device firms, and regulatory specialists. These conversations provided insight into procedural preferences, handling characteristics, and clinical endpoints that matter most to adoption decisions. Secondary research involved thematic review of peer-reviewed literature, regulatory guidance documents, clinical trial registries, and publicly available technical standards to triangulate performance claims and safety considerations.

Analytical frameworks included segmentation mapping across applications, product types, form factors, end users, and distribution channels, enabling cross-sectional analysis of adoption barriers and commercial levers. Supply chain stress-testing scenarios were constructed to evaluate responses to cost shocks and tariff changes, emphasizing operational tactics such as localized production and BOM substitution. Data validation procedures combined cross-interview corroboration with document-level evidence, and findings were iteratively refined through expert review sessions. This mixed-method approach ensures that the report's insights reflect both lived clinical experience and the rigor of technical and regulatory documentation.

Conclusive synthesis highlighting how coordinated product, evidence, and supply strategies will determine the trajectory and clinical impact of bioactive glass technologies

In summary, bioactive glass stands at a juncture where matured material science, nuanced clinical needs, and evolving commercial structures are creating tangible pathways to broader adoption. The technology's core strengths-bioactivity, tunable dissolution, and capacity for functional ion release-align closely with clinical objectives in dental repair, orthopedic regeneration, and engineered tissues. However, realizing the full potential of these materials requires coordinated action across product design, clinical evidence generation, and supply chain strategy.

Leaders who prioritize modular product platforms, proactive regulatory engagement, and diversified manufacturing footprints will be better equipped to navigate policy-induced cost pressures and regional market complexities. Similarly, strategic partnerships that bundle technical capability with clinical training and distribution reach will reduce friction during clinician adoption. Ultimately, the trajectory of bioactive glass will be determined not only by laboratory innovation but by the capacity of organizations to translate material advantages into reproducible, cost-effective clinical outcomes that satisfy regulators, payers, and providers alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of bioactive glass composites with 3D printed scaffolds for bone tissue regeneration
  • 5.2. Development of multifunctional bioactive glass nanofibers for targeted drug delivery applications
  • 5.3. Expansion of bioactive glass coatings for orthopedic implants to enhance antibacterial properties
  • 5.4. Adoption of sustainable bioactive glass production methods using agricultural waste feedstocks
  • 5.5. Rising investment in clinical trials exploring bioactive glass for dental tissue regeneration therapies
  • 5.6. Growth of bioactive glass-based wound dressings incorporating antibacterial silver nanoparticles
  • 5.7. Collaborations between biotech firms and academic institutions accelerating bioactive glass innovation pipelines
  • 5.8. Increasing use of doped bioactive glass formulations to stimulate vascularization in tissue engineering

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioactive Glass Market, by Application

  • 8.1. Dentistry
    • 8.1.1. Endodontic Applications
    • 8.1.2. Periodontal Treatment
  • 8.2. Drug Delivery
  • 8.3. Orthopedics
    • 8.3.1. Bone Regeneration
    • 8.3.2. Spinal Fusion
  • 8.4. Tissue Engineering
    • 8.4.1. Bone Tissue
    • 8.4.2. Cartilage Tissue
    • 8.4.3. Vascular Tissue

9. Bioactive Glass Market, by Product Type

  • 9.1. 13-93
  • 9.2. 45S5
  • 9.3. 58S
  • 9.4. S53P4

10. Bioactive Glass Market, by Form

  • 10.1. Coating
  • 10.2. Powder
  • 10.3. Putty
  • 10.4. Scaffold

11. Bioactive Glass Market, by End User

  • 11.1. Dental Clinics
  • 11.2. Hospitals
  • 11.3. Research Institutes

12. Bioactive Glass Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors

13. Bioactive Glass Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bioactive Glass Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bioactive Glass Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Stryker Corporation
    • 16.3.2. 3M Company
    • 16.3.3. NovaBone Products, LLC
    • 16.3.4. Mo-Sci Corporation
    • 16.3.5. Bonalive Biomaterials Ltd
    • 16.3.6. Biomin GmbH
    • 16.3.7. Orthovita, Inc.
    • 16.3.8. Shanghai Bio-lu Biomaterials Co., Ltd.
    • 16.3.9. CoorsTek, Inc.
    • 16.3.10. AGC Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOACTIVE GLASS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOACTIVE GLASS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOACTIVE GLASS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOACTIVE GLASS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOACTIVE GLASS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOACTIVE GLASS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ENDODONTIC APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PERIODONTAL TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY BONE TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY CARTILAGE TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY VASCULAR TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 13-93, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 45S5, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY 58S, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY S53P4, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COATING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY SCAFFOLD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. GCC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GCC BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. GCC BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. GCC BIOACTIVE GLASS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. GCC BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2018-2024 (USD MILLION)
  • TABLE 336. GCC BIOACTIVE GLASS MARKET SIZE, BY DENTISTRY, 2025-2032 (USD MILLION)
  • TABLE 337. GCC BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 338. GCC BIOACTIVE GLASS MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 339. GCC BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 340. GCC BIOACTIVE GLASS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 341. GCC BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. GCC BIOACTIVE GLASS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 343. GCC BIOACTIVE GLASS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 344. GCC BIOACTIVE GLASS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 345. GCC BIOACTIVE GLASS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. GCC BIOACTIVE GLASS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 347. GCC BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 348. GCC BIOACTIVE GLASS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 349. EUROPEAN UNION BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. EUROPEAN UNION BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. EUROPEAN UNIO